Tanzania to set up generic ARVs manufacturing plant
The facility which will begin commercial production of the drugs in January 2012, is expected to manufacture at least 100 million tablets every year, theeastafrican.co.ke reported. The generic
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
The partnership intends to support product development regulatory compliance goals. Lancaster Laboratories provides GMP and GLP services, including protein characterization, cell bank testing, viral clearance studies and method